Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1069 per EA under NDC 69097012515. Its NADAC has been published 596 times since Jan 28, 2015.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097012515
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA076343On Market Since
6/12/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 596 times since Jan 28, 2015, and over the history we have for it it has declined 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1069 per EA |
|---|---|
| All-time high | $0.1389 (Jul 15, 2015) |
| All-time low | $0.0880 (Apr 17, 2024) |
| 52-week high | $0.1092 |
| 52-week low | $0.1009 |
| Median price | $0.1107 |
| Average price | $0.1118 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 596 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Cipla USA Inc., is $0.1069 per EA (NDC 69097012515), effective Jun 24, 2026.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 14.9%. It has been tracked across 596 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Jan 28, 2015, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1389 (Jul 15, 2015), with a median of $0.1107 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 18% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 69097012515) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification